MacDee, Inc.

MacDee, Inc. is a specialized manufacturer of orthopedic medical devices, focusing on innovative solutions that enhance surgical procedures and patient outcomes in the orthopedic market. MacDee, Inc. is involved in the manufacturing of orthopedic medical devices.

The company was founded in 1964 and is headquartered in Chelsea, US. In September 2006, Orchid Orthopedic Solutions acquired MacDee, Inc. The deal details are not disclosed. Orchid Orthopedic Solutions specializes in the manufacturing and development of orthopedic medical devices, focusing on innovative solutions for orthopedic implant procedures.

The company's core product offerings encompass a diverse range of cementless orthopedic implants, designed to enhance patient outcomes by promoting bone ingrowth and stability. Orchid collaborates closely with clients throughout the product design phase to ensure efficient manufacturability, streamlining the process from concept to finished goods. Their extensive portfolio serves major orthopedic markets across North America, Europe, and Asia, catering to hospitals, surgical centers, and orthopedic device manufacturers. By simplifying the supply chain and providing a comprehensive approach—from forming to packaging—Orchid aims to accelerate the path to market for new orthopedic products.

Orchid Orthopedic Solutions generates revenue primarily through B2B partnerships with medical device manufacturers and healthcare providers. The company engages in direct sales transactions, allowing clients to place orders for finished orthopedic implants and related services, focusing on long-term partnerships. Revenue is structured around single purchase orders, enabling clients to acquire a range of products through one transaction, enhancing efficiency and reducing administrative overhead. Specific pricing plans for individual products and services are tailored based on each client's unique requirements, ensuring competitive pricing in the marketplace.

The revenue model emphasizes collaborative development projects, such as advancements in cementless knee designs, underscoring Orchid's commitment to innovation in orthopedic manufacturing. The most recent deal involving MacDee, Inc. occurred in September 2006, when Orchid Orthopedic Solutions, a portfolio company of Churchill Equity, acquired the firm. This acquisition is expected to enhance Orchid's capabilities in the orthopedic sector and expand its product offerings.

Future growth strategies include designing and launching new orthopedic products, with a particular focus on cementless implant technologies. Moreover, Orchid aims to penetrate additional markets in Europe and Asia by 2024, utilizing its established partnerships. The integration of MacDee's resources is anticipated to support these initiatives, reinforcing Orchid's position in the orthopedic market.